Skip to main content

Advertisement

Table 4 Cost effectiveness results of the base case analysis

From: Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy

Comparison New technology Comparator Incremental costs Incremental QALYs Cost per QALY gained
New tech Comparator Costs QALYs Costs QALYs
HPV9 girls HPV4 girls €183.29 27.53857 €180.60 27.53797 2.69 0.0006 €4483
HPV9 girls HPV2 girls €183.29 27.53857 €188.92 27.53571 −5.63 0.00286 Cost saving
HPV9 universal HPV4 universal €213.64 27.54041 €206.63 27.53974 7.01 0.00067 €10,463
HPV9 universal HPV4 girls €213.64 27.54041 €180.60 27.53797 33.04 0.00244 €13,541